Received Jun 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (RECOMBIVAX HB) | MERCK & CO. INC. | 1 | — | — |
HCP was looking to see if a 23 year old who had previously received a single pediatric dose, have sufficient immunity for Hepatitis B.; No additional AE/PQC; This spontaneous report was received from a healthcare professional (HCP) and refers to a currently 23 year old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On an unknown date, the patient was vaccinated with a single pediatric dose of Hepatitis B Vaccine (Recombinant) (RECOMBIVAX HB) (exact dose, route of administration, vaccination site, lot # and expiration date were not reported) administered for prophylaxis (inappropriate schedule of product administration). The reporter was looking to see if the patient had sufficient immunity for Hepatitis B. The reporter refused to provide demographic information and no additional information was provided. No additional adverse event (AE) or product quality complaint (PQC) was noted.